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Abstract: A new Cu(II) complex is synthetized by the reaction of copper nitrate and a N-acylhydrazone
ligand obtained from the condensation of o-vanillin and 2-thiophecarbohydrazide (H2L). The solid-
state structure of [Cu(HL)(H2O)](NO3)·H2O, or CuHL for simplicity, was determined by X-ray
diffraction. In the cationic complex, the copper center is in a nearly squared planar environment
with the nitrate interacting as a counterion. CuHL was characterized by spectroscopic techniques, in-
cluding solid-state FTIR, Raman, electron paramagnetic resonance (EPR) and diffuse reflectance and
solution UV-Vis electronic spectroscopy. Calculations based on the density functional theory (DFT)
assisted the interpretation and assignment of the spectroscopic data. The complex does not show
relevant antioxidant activity evaluated by the radical cation of 2,2′-azinobis(3-ethylbenzothiazoline-
6-sulfonic acid) diammonium salt (ABTS) method, being even less active than the free ligand as a
radical quencher. Cytotoxicity assays of CuHL against three human tumor cell lines, namely MG-63,
A549 and HT-29, revealed an important enhancement of the effectiveness as compared with both the
ligand and the free metal ion. Moreover, its cytotoxic effect was remarkably stronger than that of the
reference metallodrug cisplatin in all cancer cell lines tested, a promissory result in the search for
new metallodrugs of essential transition metals.
Keywords: copper(II) complex; N-acylhydrazone; spectroscopy; XRD crystal structure; DFT calcula-
tions; anti-cancer activity
1. Introduction
Copper(II) is associated to systems involved in biological processes such as oxygen or
electron transport [1]. Due to its low redox potential, it can participate in oxidative enzy-
matic reactions, being one of the essential metal ions in metabolic processes of the human
organism [2]. In addition to cellular respiration, this metal is involved in the formation of
pigments, the biosynthesis of neurotransmitters and the formation of connective tissue,
among other processes [3,4].
Copper coordination chemistry has gained importance as many compounds showed
interesting chemical and therapeutic properties such as catalytic, analytical, antibacterial,
anti-inflammatory and anti-proliferative properties of tumor cells, enhancing the activity
of the respective free ligands [5–12].
Among the broad diversity of organic ligands with relevant properties, copper coordi-
nation compounds with Schiff bases (SB) were reported. SBs are a family of compounds
characterized by the presence of the azomethine group in their chemical structure. They
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are of interest in a variety of application fields, including analytical, biological and in-
organic chemistry. In recent decades, they have acquired importance in medicine and
pharmacology due to their anti-inflammatory, analgesic, anti-microbial, anti-convulsant,
anti-tuberculosis, anti-tumor and antioxidant activity, among other properties [13–20].
N-acylhydrazones constitute a particularly interesting group included in the BS family.
The presence of the [O=C(R)–NH–N=C<] function and their structural characteristics pro-
vide high stability and special properties to the molecule. Acting as ligands, they lead to
the formation of coordination compounds with biological activity [21–23]. Particularly,
the compound 2-acetylthiophene-2-hydroxy-3-methoxybenzohydrazone monohydrate,
previously named o-HVATPNNH and hereafter referred to as H2L, has been previously
synthesized and structurally characterized [24] and has the conditions of an effective
ligand. The precursors used to obtain the ligand were selected taking into account that
(i) o-vanillin (3-methoxysalicilaldehyde or 2-hydroxy-3-methoxybenzaldehyde) showed
antioxidant activity, low toxicity and strong tendency to combine with amine derivatives,
generating stable ligands [23,25,26], and that (ii) thiophene (five-membered heterocyclic
with sulfur as the heteroatom) and its derivatives have been widely studied for their thera-
peutic applications [27,28], showing good results as anti-tumor agents [29,30], analgesic
and anti-inflammatory [31], anti-hypertensive [32], anti-diabetic [33], cholesterol activity
inhibitors [34], anti-allergenic [35] and antioxidant agents [36], constituting a group of com-
pounds of both pharmacological and agrochemical interest for their bactericidal, fungicidal
and herbicidal activity.
In this work, we report the synthesis of a Cu(II) complex obtained by the reaction
of a salt of this metal and the H2L ligand, hereafter named CuHL for short, and discuss
its characterization, including crystal structure determination, spectroscopic analysis and
density functional theory (DFT) calculations, together with its antioxidant effect and
cytotoxic activity against a panel of human cancer cells. Promissory results have been
achieved in the search for new therapeutic agents of essential transition metals having less
toxicity than the reference platinum metallodrugs.
2. Results and Discussion
2.1. Syntheses
The ligand H2L was prepared according to the reported procedure [24]. To obtain the
complex, an ethanolic solution of H2L was added to a solution of copper (II) salt in the
same solvent, according to the reaction depicted in Scheme 1. The reaction was held under
stirring and mild heating conditions, and dark green crystals of the complex were obtained
from the solution after some weeks. More details can be found in the Experimental section.
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Scheme 1. Synthesis of the complex [Cu(HL)(H2O)](NO3)·H2O (CuHL).
2.2. Crystal Structure
Crystal data and structure refinement results for [Cu(HL)(H2O)](NO3)·H2O are listed
in Table 1. Figure 1 shows an Oak Ridge Thermal Ellipsoid Plot (ORTEP) [37] plot of the
solid-state molecule, and selected bond distances and angles are listed in Table 2.
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Z, density (calculated) 2, 1.714 Mg/m3
Absorption coefficient 3.442 mm−1
F(000) 446
θ-range for data collection 4.17 to 72.41◦
Index ranges −9 ≤ h ≤ 11, −11 ≤ k ≤ 9, −14 ≤ l ≤ 13
Reflections collected 7440
Independent reflections 3335 [R(int) = 0.023]
Observed reflections [I > 2σ(I)] 2989
Completeness to θ = 72.41◦ 99.4%
Refinement method Full-matrix least-squares on F2
Data/restraints/parameters 3335/6/252
Goodness-of-fit on F2 1.047
Final R indices [I > 2σ(I)] R1 = 0.0449, wR2 = 0.1264
R indices (all data) R1 = 0.0496, wR2 = 0.1323
Largest diff. peak and hole 0.641 and −0.555 e.Å−3




Figure 1. Drawing of CuHL showing the labeling of the non-H atoms and their displacement ellip-
soids at the 30% probability level and the planarity of the coordination environment. 
Due to the coordination of the tridentate ligand with the Cu(II) ion, two coordination 
rings are formed, one of five and the other of six members, which promote the planarity 
of the environment, as can be seen in Figure 1. 
Geometry optimizations were carried out using the experimental structure as a start-
ing point and within the framework of the DFT. As the nitrate anion is a counterion, it 
was not considered in a first set of calculations. However, the results of those calculations 
indicated that the metal ion coordination sphere deviates from the planarity. A second set 
of calculations, including the nitrate ion, allows the complex to recover its planar coordi-
nation around the metal ion. Thus, the final optimized structure used to obtain structural 
and spectroscopic properties contains the nitrate ion. 
Table 2 compares the experimental and calculated values for selected structural pa-
rameters. It can be seen in the table that the agreement is very good, especially for dihedral 
angles that determine the spatial conformation of the complex. The experimental and the 
calculated structures are superimposed in Figure 2, making clear the goodness of the op-
timized geometry. Tables S5–S7 provide an extensive list of the calculated bond distances, 
bond angles and dihedral angles, respectively. 
 
Figure 2. Comparison of the experimental (a) and calculated (b) geometries of CuHL. 
Table 2. Selected experimental and calculated geometric parameters of CuHL. 
Bond Distances (Å) Bond Angles (°) 
 Exp. Calc.  Exp. Calc. 
Cu–N1 1.927 1.957 N1–Cu–O3 81.6 79.4 
Cu–O1 1.885 1.915 Cu–N1–N2 111.7 112.1 
Cu–O1W 1.953 1.990 N1–Cu–O1 92.8 91.1 
Cu–O3 1.978 2.094 O1–Cu–O3 174.4 161.8 
Cu–O31 2.429 2.257 O1W–Cu–N1 167.8 173.0 
O1–C1 1.311 1.285 O1W–Cu–O1 92.4 94.5 
N1–C7 1.290 1.297 N1–Cu–O31 98.0 92.3 
N1–N2 1.376 1.374 O3–Cu–O1W 93.1 94.0 
C8–N2 1.342 1.354 O3–Cu–O31 96.6 89.2 
C8–O3 1.258 1.247 O1–Cu–O31 84.2 106.9 
Figure 1. Drawing of CuHL showing the labeling of the non-H atoms and their displacement
ellipsoids at the 30% probability level and the planarity of the coordination enviro ment.
The cationic complex crystallizes with the Cu(II) ion at the center of a nearly square
environment, coordinated by the HL− anion (by loss of the phenolic proton) acting as a
tridentate ligand through the phenolic oxygen [d(Cu–O) = 1.885(3) Å], the imine nitrogen
[d(Cu–N) = 1.927(2) Å] and the carbonyl oxygen [d(Cu–O) = 1.978(3) Å] and by a water
molecule [d(Cu–Ow) = 1.953(2) Å]. The metal is capped by one oxygen atom of the nitrate
counterion at a contact distance of 2.429(5) Å.
The crystal is further stabilized by a net of intermolecular H-bonds involving, as
donors, the HL− amine group and the water molecules (w1 and w2) and, as acceptors, the
crystallization water molecule (w2) and the nitrate and HL− methoxy and carbonyl oxygen
atoms. The H-bonding structure is detailed in Table S1 of the Supplementary Materials.
In the crystal packing (Figure S1), the layered arrangement of the cationic complexes can
be appreciated.
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Table 2. Selected experimental and calculated geometric parameters of CuHL.
Bond Distances (Å) Bond Angles (◦)
Exp. Calc. Exp. Calc.
Cu–N1 1.927 1.957 N1–Cu–O3 81.6 79.4
Cu–O1 1.885 1.915 Cu–N1–N2 111.7 112.1
Cu–O1W 1.953 1.990 N1–Cu–O1 92.8 91.1
Cu–O3 1.978 2.094 O1–Cu–O3 174.4 161.8
Cu–O31 2.429 2.257 O1W–Cu–N1 167.8 173.0
O1–C1 1.311 1.285 O1W–Cu–O1 92.4 94.5
N1–C7 1.290 1.297 N1–Cu–O31 98.0 92.3
N1–N2 1.376 1.374 O3–Cu–O1W 93.1 94.0
C8–N2 1.342 1.354 O3–Cu–O31 96.6 89.2
C8–O3 1.258 1.247 O1–Cu–O31 84.2 106.9
O31–N3 1.217 1.272 O1W–Cu–O31 93.6 90.2
C2–O2 1.365 1.353 N3–O31–Cu 136.4 127.0
O2–C13 1.420 1.416
N3–O32 1.212 1.275 Dihedral Angles (◦)
N3–O33 1.217 1.216 Exp. Calc.
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2.3. Vibrational Spectroscopy
FTIR and Raman spectra of solid samples of CuHL were recorded in the 4000–400 cm−1
frequency range and analyzed in comparison with those obtained for the free ligand
H2L [24] and are shown in Figure S2. Harmonic vibrational frequencies were also calculated
at the DFT level of theory used for geometry optimization and were used to help in the
assignment of experimental bands. No factors were used to scale the calculated frequencies.
A complete table of vibrational spectroscopic results is available in the Supplementary
Materials (Table S8).
The IR bands assigned to the OH group of the free ligand disappear in the spectrum
of the complex, hence confirming the deprotonation of the phenolic oxygen and forward
coordination of the phenoxide to the copper center.
According to the calculations, the C=O and C=N stretching modes are coupled, giving
rise to a broad and intense band at 1606 cm−1 in the IR spectrum and to an intense Raman
signal at 1618 cm−1, with a shoulder at 1603 cm−1. The presence of these signals, together
with those due to the out-of-plane and in-plane NH bending, in the spectra of the complex
is in accordance with the keto-amino tautomeric form of the coordinated ligand.
The shift to lower frequencies of the νC=O band, located a 1640 cm−1 in the ligand
spectrum, denotes the effect of the coordination of Cu(II) through the oxygen atom. The
bands observed at 541 (IR) and 544 cm−1 (Raman), assigned to the O–Cu–O stretching,
also confirm the coordination of the metal to the carbonyl group and to the phenoxide
oxygen of the ligand. Two signals at 463 and 456 cm−1 in the IR spectrum were assigned to
the Cu–O (water) and Cu–N (ligand) stretching modes, respectively. These values are in
accordance with the calculated frequencies.
The strong band at 1561 cm−1 is assigned to the stretching of the o-VA ring coupled
to the in-plane deformation of the N–H group and is related to the weak Raman signal
at 1565 cm−1. As expected, most vibrational modes of the rings in the ligand are not
significantly affected, since they are not directly involved in the coordination.
Regarding the NO3− counterion, four main bands are expected at approximately 1390,
1050, 831 and 720 cm−1, which are assigned to the stretching and in- and out-of-plane
deformation of the nitrate group [38]. In the spectrum of the complex, it was possible to
find an intense band at 1384 cm−1 and another of lower intensity at 1057 cm−1. The other
bands were difficult to identify due to their low intensity, as they can be overlapped by
more intense signals related to CH bonds in the same region.
2.4. EPR Spectroscopy
The electron paramagnetic resonance (EPR) spectrum of a polycrystalline sample of
CuHL recorded at 298 K is shown in Figure 3 together with its simulation.




Figure 3. Electron paramagnetic resonance (EPR) spectrum of CuHL at 298 K (____) and the best fit 
(_ _ _ _). 
The simulated spectrum is in accordance with an orthorhombic symmetry, with cal-
culated g-tensor values of g1 = 2.273, g2 = 2.068 and g3 = 2.052. The calculated G value (Equa-
tion (1)) was 4.55, thus indicating that the exchange interactions between the paramagnetic 
centers are negligible [39] and, therefore, that the complex behaves as a monomeric spe-
cies, as observed by XRD. = ∥ − 2− 2 (1)
Additionally, the R parameter was obtained according to Equation (2), giving a value 
of 0.078. This result suggests the predominance of a d(x2 − y2) ground state for the unpaired 
electron [40–43], in agreement with the geometry evidenced by the crystal structure. = −   −        > >  (2)
2.5. Electronic Spectroscopy 
The UV-Visible spectra of CuHL were recorded in dimethyl sulfoxide (DMSO) solu-
tion at 1 × 10−4 M and 1 × 10−2 M to selectively register bands with very different molar 
absorptivities. Spectra of both solutions were recorded several times for 72 h without sig-
nificant changes, showing stability within this period. The absorption spectrum of a solid 
sample was also obtained by transformation with the Kubelka–Munk equation from the 
diffuse reflectance measurement [44]. The results are depicted in Figure 4 and are ana-
lyzed in comparison with the spectrum of the free ligand. 
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Table 3. Experimental and calculated electronic spectra of the complex in DMSO solution and
solid sample. Band maximum and transition energies are given in nm. The molar absorptivity
(in M−1·cm−1) and calculated oscillator strength (O.S.) (in atomic units) are in parentheses. The
proposed assignment is also given.
Experimental






743 (43) 715 ** 843 (0.00023) Hβ −9→ Lβ d→ d
657 (35) 637 ** 670 (0.00040) Hβ −15→ Lβ d→ d
423 (sh)















345 (0.30163) Hα → Lα+1 Intraligand
335 (1.7 × 104) 287 (0.48728) Hβ −5→ Lβ LMCT
320 (sh) 264 (0.10541) Hα −5→ Lα Intraligand
258 * 246 (0.02130) Hα −1→ Lα+1 Intraligand
* Solvent cut off. ** Values obtained by deconvolution. (a) H and L are used as short notations for HOMO and
LUMO, respectively, whereas α and α refer to the electronic spin channels. (sh): shoulder.
The calculations predicted four d–d transitions at 843, 670, 581 and 573 nm. Two
of them, at lower energy and assigned to d(xy)→d(x2 − y2) and d(z2)→d(x2 − y2) tran-
sitions, are located at 657 and 743 nm following the deconvolution of the broad band,
with a maximum near 700 nm. The more energetic transitions (d(yz)→d(x2 − y2) and
d(xz)→d(x2 − y2)) are expected to give rise to closely located bands, which could not be
distinguished by deconvolution and are probably overlapped with the more intense band
with a maximum at 411 nm, with a shoulder at approximately 423 nm. Thus, the latter
band can be assigned to both d–d and ligand-to-metal charge transfer (LMCT) transitions.
The discrepancies observed between the calculated and the experimental transition ener-
gies can be attributed to the small differences between the experimental and calculated
bond lengths.
The spectrum recorded for the solid sample shows a similar behavior to that obtained
for the solution. The differences in the maximum positions can be attributed to the intrinsic
differences in the measurement techniques and the deconvolution process. Despite the
possible interaction of the solvent, changes in the coordination geometry would have led
to more significant changes in the spectra; thus, it can be inferred that there are no relevant
changes in the coordination environment of CuHL from the solid to the DMSO solution.
By comparison with the free ligand spectrum and according to the calculations, the
set of bands in the solution spectrum of the complex observed at 348, 335 and 320 nm and
the corresponding broad band recorded for the solid sample at 330 nm are assigned to
intraligand and LMCT transitions.
2.6. Cell Viability Study
Cell viability assays were performed for H2L and CuHL with three tumor cell lines,
namely MG-63 (human osteosarcoma), A549 (lung adenocarcinoma) and HT-29 (colorectal
adenocarcinoma), and one non-tumor cell line, L929 (mouse-derived fibroblast).
Table 4 shows the IC50 values and the selectivity index (SI) of CuHL and the reference
metallo-drug cisplatin (CDDP). As can be seen, the complex induced cytotoxicity on MG-
63, A549 and HT-29 from 1 to 8 µM (p < 0.01). Nevertheless, the compound only has
a good selectivity on MG-63 (SI = 1.8). On the other hand, the IC50 values of the free
ligand and free metal cations are higher than 100 µM for the three cell lines tested, hence
revealing the key role of complexation to modulate the anti-cancer activity of this type of
compound. This effect was described in many scientific reports for copper and other metal
complexes [48,49].
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Table 4. IC50 values (µM) and selectivity index (SI) of CuHL and CDDP on MG-63, HT-29, A549 and
L929 cell lines after 24 h of incubation.
Cell Lines IC50 CuHL SI CuHL IC50 CDDP SI CDDP
MG-63 2.0 ± 0.5 1.8 39 ± 1.8 0.3
HT-29 7.4 ± 0.9 0.5 178.8 ± 4.9 0.06
A549 3.1 ± 0.6 1.2 114.0 ± 2.3 0.1
L929 3.6 ± 0.3 11.2 ± 1.6
With the aim to establish the anti-cancer potency of CuHL, its effects on cell viability
were compared with those of the clinical reference CDDP on the cancer panel cell lines
tested. As it can be seen in Table 5, the complex is significantly more cytotoxic than CDDP
on all tested tumor cells. Besides, CuHL showed a remarkably stronger selectivity than
CDDP on MG-63 cells (SI(CuHL) 1.8 vs. SI(CDDP) 0.3 *).




Our results indicate that the CuHL displayed a selective action on human bone
cancer cells. Scientific reports showed that copper complexes with IC50 values in the
low micromolar range (<10 µM) have been recognized as potent cytotoxic agents against
different human cancer cell lines [8]. In this sense, previous results of our group on a
copper(II) complex with a tridentate ONO acylhydrazone ligand with benzene rings [50],
showed higher IC50 values than CuHL for MG-63 (8.8 ± 0.3 µM) and A549 (12 ± 1.2 µM),
hence suggesting that the thiophene ring may play some role in the anti-cancer activity
of the metal complex. Besides, the biological effects of four Cu(II) complexes with Schiff
base ligands on human colon carcinoma cells (HT-29) have been also investigated. All of
them exhibited cytotoxic effects, with IC50 values between 0.6 to 31 µM [50], and induced
the mitochondria-dependent pathway of apoptosis [51]. Another Schiff base compound,
Cu(BrHAP)2, demonstrated a potent anti-tumor effect in HT-29 cells (IC50 = 2.87 ± 0.2)
and induced elevation of reactive oxygen species (ROS) production and activation of
caspases 3/7 and 9 [52]. Furthermore, the synthesis of nine salicylaldehyde pyrazole
hydrazone (SPH) derivatives and their corresponding copper complexes (Cu–SPHs) were
reported. Cell viability studies showed that all the SPHs as well as Cu–SPHs had potent
inhibitory effects on A549 cells. However, Cu–SPHs showed stronger growth-inhibitory
effects (IC50 = 1.87 to 3.5 µM) than their corresponding SPHs (3.5 to 11 µM), demonstrating
the beneficial actions of complexation [53].
Finally, our previous results on an oxidovanadium(IV) complex with other thiophenes
containing Schiff base ligands, showing a much higher IC50 value on MG-63 cells than
CuHL, demonstrate the importance of the nature and the environment geometry of the
metal center in the effectiveness of metallo-drugs [54].
2.7. Antioxidant Activity
The antioxidant activity of the ligand and the complex was evaluated by the ABTS
radical decoloration method. Figure 5 shows the inhibition of ABTS+· radical plots.
The antioxidant activity was calculated using Trolox as a reference antioxidant through
the Trolox equivalent antioxidant capacity (TEAC) index. The values, obtained as described
in the experimental section, are presented in Table 5.
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is not an efficient antioxidant agent. Figure 6 shows the percentage of ABTS+· radicals
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with 100% corresponding to the absence of any compound to be tested.
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Absolute ethanol (Soria) and Cu(NO3)2·2.5H2O (Riedel de Haën) were used as pro-
vided. The ligand H2L was prepared from 2-thiophencarbohydrazide (TPNNH) and o-
vanillin (o-HVA), according to the reported procedure [24]. The CuHL complex was pre-
pared with addition of an ethanolic solution of H2L (0.1476 g, 0.5 mmol in 25 mL) to 25 
mL of a copper (II) penta-hemi-hydrate nitrate solution (0.3772 g, 1.6 mmol) in the same 
solvent. The reaction was held under stirring and mild heating conditions for 30 min and 
a dark green solution was obtained. After approximately two months, dark green crystals 
of the complex were obtained. They were isolated by filtration and stored in a desiccator. 
Elemental analyses were performed using an Exeter CE 440 analyzer (Exeter Analytical, 
UK) and melting point was measured using a Bock monoscop ‘‘M’’ instrument. The solid 
decomposed at 179 °C; thus, its melting point could not be determined (yield: 67%, 0.1462 
g). Anal. found: C, 35.9%; H, 3.4%; N, 10.1%; S, 7.3%; calc. for C13H15CuN3O8S: C, 35.7%; 
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3.2. X-ray Diffraction Data 
The X-ray diffraction data of CuHL were obtained from measurements on an Oxford 
Xcalibur Gemini, Eos CCD diffractometer with graphite monochromated CuKα (λ = 
1.54178 Å) radiation (http://www.agilent.com, Santa Clara, CA, United States). X-ray diffraction 
intensities were recorded (ω scans with θ and κ-offsets), integrated and scaled with Crys-
AlisPro [55] software (Oxford Diffraction Ltd, version 1.171.33.48). Unit cell parameters were 
obtained by least-squares refinement (based on the angular settings for all collected re-
flections with intensities larger than seven times the standard deviation of measurement 
errors) using CrysAlisPro. The data were corrected empirically by absorption, using the 
multi-scan method included in CrysAlisPro. The structure was solved by the intrinsic 
phasing procedure implemented in SHELXT [56] and the corresponding non-H molecular 
model refined with anisotropic displacement parameters with SHELXL [57]. The hydro-
gen atoms of the organic ligand were located at their expected geometrical positions and 
refined with the riding model. The methyl H-atom positions were optimized by treating 
the –CH3 group as a rigid one allowed to rotate around the O–CH3 bonds so as to maxim-
ize the sum of the electron densities at the calculated positions. The methyl group con-
verged to a staggered angular conformation. The water H-atoms were located in a differ-
ence Fourier map and refined at their found positions, with isotropic displacement pa-
rameters and Ow–H and H…H distances restrained to target values of 0.86(1) and 1.36(1) 
Å, respectively. 
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3. Materials and Methods
3.1. Synthesis
Absolute ethanol (Soria) and Cu(NO3)2·2.5H2O (Riedel de Haën) were used as pro-
vided. The ligand H2L was prepared from 2-thiophencarbohydrazide (TPNNH) and
o-vanillin (o-HVA), according to th rep rted pr cedure [24]. The CuHL complex was
prepared with addition of an ethanolic solution of H2L (0.1476 g, 0.5 mmol in 25 mL) to
25 mL of a copper (II) penta-hemi-hydrate nitrate solution (0.3772 g, 1.6 mmol) in the
same solvent. The reaction was held under stirring and mild heating conditi ns for 30 min
and a dark g en solution was obtained. After approxim tely two m ths, dark green
crystals of the complex were obtained. They were iso ated by filtration and stored in a
desiccat r. Elemental an lyses were performed using an Exeter CE 440 analyzer (Exe e
Analytical, UK) and m lting p int was measured using a Bock monoscop “M” instrument.
The soli d composed at 179 ◦C; thus, its melting point could not be determined (yield:
67%, 0.1462 g). Anal. found: C, 35.9%; H, 3.4%; N, 10.1%; S, 7.3%; calc. for C13H15CuN3O8S:
C, 35.7%; H, 3.5%; N, 9.6 ; S, 7.3 .
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3.2. X-ray Diffraction Data
The X-ray diffraction data of CuHL were obtained from measurements on an Ox-
ford Xcalibur Gemini, Eos CCD diffractometer with graphite monochromated CuKα
(λ = 1.54178 Å) radiation (http://www.agilent.com, Santa Clara, CA, United States). X-ray
diffraction intensities were recorded (ω scans with θ and κ-offsets), integrated and scaled
with CrysAlisPro [55] software (Oxford Diffraction Ltd, version 1.171.33.48). Unit cell
parameters were obtained by least-squares refinement (based on the angular settings for
all collected reflections with intensities larger than seven times the standard deviation of
measurement errors) using CrysAlisPro. The data were corrected empirically by absorption,
using the multi-scan method included in CrysAlisPro. The structure was solved by the
intrinsic phasing procedure implemented in SHELXT [56] and the corresponding non-H
molecular model refined with anisotropic displacement parameters with SHELXL [57].
The hydrogen atoms of the organic ligand were located at their expected geometrical
positions and refined with the riding model. The methyl H-atom positions were optimized
by treating the –CH3 group as a rigid one allowed to rotate around the O–CH3 bonds so
as to maximize the sum of the electron densities at the calculated positions. The methyl
group converged to a staggered angular conformation. The water H-atoms were located in
a difference Fourier map and refined at their found positions, with isotropic displacement
parameters and Ow–H and H . . . H distances restrained to target values of 0.86(1) and
1.36(1) Å, respectively.
Crystallographic structural data have been deposited at the Cambridge Crystal-
lographic Data Centre (CCDC). Enquiries for data can be directed to the Cambridge
Crystallographic Data Centre, 12 Union Road, Cambridge, UK, CB2 1EZ or (e-mail) de-
posit@ccdc.cam.ac.uk or (fax) +44 (0) 1223 336033. Any request to the Cambridge Crys-
tallographic Data Centre for this material should quote the full literature citation and the
reference number CCDC 2046671.
3.3. Spectroscopy
Infrared spectra of solid samples (KBr pellets) were recorded with a Bruker Equinox
55 instrument (Billerica, MA, United States) in the 4000–400 cm−1 region. Raman spectra
were measured with a WITEC alpha 300 RA spectrophotometer (https://www.witec.de/),
using a laser excitation wavelength of 532 nm and a 20x objective lens.
Electronic spectra of the complex and ligand were measured using a Shimadzu UV-
2006 spectrophotometer (https://www.shimadzu.com/). UV-Vis spectra were recorded in
a solution of dimethyl sulfoxide (DMSO) using 10 mm quartz cells in the spectral range
from 250 to 800 nm. The diffuse reflectance spectrum of solid samples was recorded using
a BaSO4 pellet as a reference with an integrating sphere attachment, in the 250–800 nm
range, and it was forward-converted to absorbance using the Kubelka–Munk function [44].
X-band electron paramagnetic resonance spectra were measured on a polycrystalline
sample of the complex in the 298–120 K range. A Bruker EMX spectrometer was used,
equipped with a Bruker ER 036TM NMR-Tesla meter, an Agilent 53150A microwave fre-
quency meter and a Bruker ER 4131VT accessory for the control of the variable temperature
measurements. Simulations of the recorded spectra were carried out using the Simfonia
Program (Version 1.25, Billerica, MA, United States) [58]. Experimental details of the
data collection: modulation amplitude, 0.1 mT; time constant, 40.96 ms; conversion time,
327.68 ms; gain, 1 × 103; power, 20 mW; and microwave frequency, 9.4258 GHz.
3.4. Computational Methods
The X-ray diffraction structure of CuHL was adopted as the starting geometry for
the calculations. The geometry of the complex was optimized in the gas phase using
the Becke’s three parameters functional [59] with the correlation functional of Lee, Yang
and Parr [60] (B3LYP), as implemented in the ORCA program (Version 3.0.3) [61]. The
triple-zeta quality Def2-TZVP basis set [62] was used for all atoms.
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The eigenvalues of the Hessian matrix of the total energy with respect to nuclear
coordinates were calculated to verify that the optimized geometries were local minima on
the potential energy surface. The eigenvalues were then transformed to harmonic vibra-
tional frequencies, which were further used to assist in the assignment of the experimental
vibrational spectra. No scale factors were applied to the calculated frequencies.
Electronic spectrum calculations were also calculated by means of time-dependent
DFT, using, in this case, the hybrid PBE0 [63] functional with the Def2-TZVP basis set.
Solvation effects were included through the conductor-like screening model (COSMO) [64].
The results were used to help in the assignment of the experimental electronic spectra.
3.5. Cell Viability Study: 3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide Assay
Cell viability assays were performed for the complex CuHL and the ligand H2L with
three tumor cell lines, MG-63 (human osteosarcoma), A549 (lung adenocarcinoma) and
HT-29 (colorectal adenocarcinoma), and one non-tumor cell line, L929 (mouse-derived
fibroblast). All the cell lines were provided by American Type Culture Collection (ATCC).
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was
performed according to Mosmann [65]. Briefly, cells were seeded in a 96-well dish for 24 h
and treated with different concentrations of compounds 1 and 2 (1–50 µM) at 37 ◦C for
24 h. Then, the medium was changed, and the cells were incubated with 0.5 mg/mL MTT
under normal culture conditions for 3 h. Cell viability was marked by the conversion of
the tetrazolium salt MTT to a colored formazan by mitochondrial dehydrogenases. Color
development was measured spectrophotometrically with a microplate reader (model 7530,
Cambridge Technology, USA) at 570 nm after cell lysis in DMSO (100 µL per well).
Cell Line and Growth Conditions
MG-63 (bone), A549 (lung) and HT-29 (colorectal) tumor cells and L929 non-tumoral
cells were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10% 2,2′-
azinobis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (FBS), 100 U/mL peni-
cillin and 100 µg/mL streptomycin at 37 ◦C in a 5% CO2 atmosphere. Cells were seeded
in a 75-cm2 flask, and cells were subcultured using 1 mL of TrypLE ™. For experiments,
cells were grown in multiwell plates. When cells reached the desired confluence, the mono-
layers were washed with PBS and were incubated under different conditions according to
the experiments.
3.6. Antioxidant Activity
Antioxidant activity was evaluated using the ABTS method by determining the Trolox
(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) equivalent antioxidant coeffi-
cient (TEAC). The radical cation of 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid)
diammonium salt (ABTS·+) was generated by incubating ABTS with potassium persul-
fate. The resultant solution was diluted in 0.1 M KH2PO4–NaOH buffer (pH 7.4) until an
absorbance of approximately 0.7 at 734 nm [66].
The antioxidant activity of the compounds was determined by measuring the ab-
sorbance of a mixture of 990 µL of the solution containing the radical and 10 µL of solution
of the tested compound (the complex, the ligand or Trolox standard) in DMSO to reach
a final concentration in the range of 0–100 µM. The reduction of ABTS+· was monitored
spectrophotometrically after 6 min of the initial mixing at 30 ◦C. Each determination was
run in triplicate.
The percentage of inhibition at each concentration was calculated related to the ab-
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The values are therefore plotted vs. concentration, and from the slope of the fitting
line, the TEAC (Equation (4)) is calculated, thus indicating the concentration of Trolox with






By means of a straightforward synthetic procedure, crystals of a Cu(II) complex
(CuHL), with a hydrazone ligand derived from o-vanillin and a thiophene hydrazide (H2L),
were obtained. The coordination compound crystalizes in the triclinic P-1 space group as
a cationic (+1) complex with a nitrate counterion. The metal is at the center of a nearly
squared environment, coordinated by the deprotonated tridentate (ONO) ligand, HL− and
a water molecule. The crystal structure was stabilized by H-bond interactions involving
crystallization water molecules and the nitrate anion. The crystal is further stabilized by
H-bond interactions involving the water molecules, the amine, methoxy and carbonyl
groups of the ligand and the nitrate counterion.
Its spectroscopic analyses in the solid state and in solution, including different tech-
niques, were complemented by DFT calculations that supported the assignment of the
vibrational and electronic spectra. The results are consistent with the tetracoordinated
metal center and the tridentate deprotonated ligand in the keto-amino tautomeric form.
The complex was shown to be stable in DMSO solution for at least 72 h, so biological
assays of cytotoxic and antioxidant activity could be developed. It was proven to be a very
good cytotoxic agent on MG-63, HT-29 and A549 tumor lines, remarkably improving the
activity of the free ligand and also showing an IC50 value lower than those considered as
promising agents in the literature. The results encourage continuation of the anti-tumor
study through more specific assays.
Regarding the antioxidant activity, it did not show improvement of the results obtained
for the free ligand, and the values obtained are not relevant.
Supplementary Materials: The following are available online at https://www.mdpi.com/2304-674
0/9/2/9/s1, Table S1: Hydrogen bonds for CuHL; Table S2: Experimental bond distances of CuHL;
Table S3: Experimental bond angles of CuHL; Table S4: Experimental dihedral angles of CuHL;
Table S5: Calculated bond distances of CuHL; Table S6: Calculated bond angles of CuHL; Table S7:
Calculated dihedral angles of CuHL; Table S8: Assignment of the vibrational spectra of CuHL and
H2L ligand; Figure S1: Drawings of CuHL showing crystal packing; Figure S2: FTIR and Raman
spectra of CuHL along with FTIR spectrum of H2L. Figure S3: Representation of OMs involved in
the electronic transitions of CuHL, CIF file (reference number CCDC 204667) and check-CIF PDF file.
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base Cu(II) complexes on signaling pathways in HT-29 cells. Mol. Med. Rep. 2016, 14, 4436–4444. [CrossRef]
52. Hajrezaie, M.; Paydar, M.; Zorofchian Moghadamtousi, S.; Hassandarvish, P.; Gwaram, N.S.; Zahedifard, M.; Rouhollahi, E.;
Karimian, H.; Looi, C.Y.; Ali, H.M.; et al. A Schiff Base-Derived Copper (II) Complex Is a Potent Inducer of Apoptosis in Colon
Cancer Cells by Activating the Intrinsic Pathway. Sci. World J. 2014, 2014, 1–12. [CrossRef] [PubMed]
53. Fan, C.D.; Su, H.; Zhao, J.; Zhao, B.X.; Zhang, S.L.; Miao, J.Y. A novel copper complex of salicylaldehyde pyrazole hydrazone
induces apoptosis through up-regulating integrin β4 in H322 lung carcinoma cells. Eur. J. Med. Chem. 2010, 45, 1438–1446.
[CrossRef] [PubMed]
54. Rodríguez, M.R.; Balsa, L.M.; Del Plá, J.; García-Tojal, J.; Pis-Diez, R.; Parajón-Costa, B.S.; León, I.E.; González-Baró, A.C. Synthesis,
characterization, DFT calculations and anticancer activity of a new oxidovanadium(IV) complex with a ligand derived from
o-vanillin and thiophene. New J. Chem. 2019, 43, 11784–11794. [CrossRef]
55. CrysAlisPro, Oxford Diffraction Ltd, version 1.171.33.48 (release 15-09-2009 CrysAlis171.NET); Oxford Diffraction Ltd: Abingdon-on-
Thames, UK, 2009.
56. Sheldrick, G.M. SHELXT—Integrated space-group and crystal-structure determination. Acta Crystallogr. Sect. A Found. Crystallogr.
2015, 71, 3–8. [CrossRef]
57. Sheldrick, G.M. A short history of SHELX. Acta Crystallogr. Sect. A Found. Crystallogr. 2008, 64, 112–122. [CrossRef]
58. WinEPR SimFonia, Version 1.25; Bruker Analytische Messtechnik GmbH: Billerica, MA, USA, 1996.
59. Yanai, T.; Tew, D.P.; Handy, N.C. A new hybrid exchange-correlation functional using the Coulomb-attenuating method (CAM-
B3LYP). Chem. Phys. Lett. 2004, 393, 51–57. [CrossRef]
60. Lee, C.; Yang, W.; Parr, R.G. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density.
Phys. Rev. B 1988, 37, 785–789. [CrossRef]
61. Neese, F. The ORCA program system. Wiley Interdiscip. Rev. Comput. Mol. Sci. 2012, 2, 73–78. [CrossRef]
62. Weigend, F.; Ahlrichs, R. Balanced basis sets of split valence, triple zeta valence and quadruple zeta valence quality for H to Rn:
Design and assessment of accuracy. Phys. Chem. Chem. Phys. 2005, 7, 3297–3305. [CrossRef]
63. Adamo, C.; Barone, V. Toward reliable density functional methods without adjustable parameters: The PBE0 model. J. Chem.
Phys. 1999, 110, 6158–6170. [CrossRef]
64. Klamt, A.; Schüürmann, G. COSMO: A new approach to dielectric screening in solvents with explicit expressions for the screening
energy and its gradient. J. Chem. Soc. Perkin Trans. 1993, 799–805. [CrossRef]
65. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J.
Immunol. Methods 1983, 65, 55–63. [CrossRef]
66. Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant Activity Applying An Improved ABTS
Radical Cation Decolorization Assay. Free Radic. Biol. Med. 1999, 26, 1231–1237. [CrossRef]
